ro 31-8220 has been researched along with methyl 2,5-dihydroxycinnamate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goekjian, P; Jochum, A; Jung, M; Kunick, C; Marshall, B; Meier, R; Saunders, L; Sippl, W; Trapp, J; Verdin, E | 1 |
| Farndale, RW; Sage, SO; Sargeant, P | 1 |
2 other study(ies) available for ro 31-8220 and methyl 2,5-dihydroxycinnamate
| Article | Year |
|---|---|
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.
Topics: Acetylation; Adenosine; Binding Sites; Cell Line, Tumor; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Models, Molecular; Molecular Mimicry; Protein Kinase Inhibitors; Sirtuins; Structure-Activity Relationship; Tubulin | 2006 |
The tyrosine kinase inhibitors methyl 2,5-dihydroxycinnamate and genistein reduce thrombin-evoked tyrosine phosphorylation and Ca2+ entry in human platelets.
Topics: Biological Transport; Blood Platelets; Blotting, Western; Calcium; Cells, Cultured; Cinnamates; Drug Interactions; Electrophoresis, Polyacrylamide Gel; Genistein; Humans; Indoles; Isoflavones; Phosphorylation; Protein Kinase C; Protein-Tyrosine Kinases; Thrombin; Tyrosine | 1993 |